메뉴 건너뛰기




Volumn 20, Issue 1, 2009, Pages 213-222

Plasma ADMA predicts restenosis of arteriovenous fistula

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CALCIUM; CREATININE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HOMOCYSTEINE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; N(G),N(G) DIMETHYLARGININE; NITRIC OXIDE; NITRITE REDUCTASE; PHOSPHATE; TRIACYLGLYCEROL;

EID: 58149489317     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2008050476     Document Type: Article
Times cited : (42)

References (45)
  • 1
    • 33745246339 scopus 로고    scopus 로고
    • Clinical practice guidelines for vascular access
    • Clinical practice guidelines for vascular access. Am J Kidney Dis 48[Suppl 1]: S176-S247, 2006
    • (2006) Am J Kidney Dis , vol.48 , Issue.SUPPL. 1
  • 3
    • 0042932664 scopus 로고    scopus 로고
    • Transforming growth factor beta1 genotype polymorphisms determine AV fistula patency in hemodialysis patients
    • Heine GH, Ulrich C, Sester U, Sester M, Kohler H, Girndt M: Transforming growth factor beta1 genotype polymorphisms determine AV fistula patency in hemodialysis patients. Kidney Int 64: 1101-1107, 2003
    • (2003) Kidney Int , vol.64 , pp. 1101-1107
    • Heine, G.H.1    Ulrich, C.2    Sester, U.3    Sester, M.4    Kohler, H.5    Girndt, M.6
  • 4
    • 0037373888 scopus 로고    scopus 로고
    • The methylentetrahydrofolate reductase C677T point mutation is a risk factor for vascular access thrombosis in hemodialysis patients
    • Fukasawa M, Matsushita K, Kamiyama M, Mikami Y, Araki I, Yamagata Z, Takeda M: The methylentetrahydrofolate reductase C677T point mutation is a risk factor for vascular access thrombosis in hemodialysis patients. Am J Kidney Dis 41: 637-642, 2003
    • (2003) Am J Kidney Dis , vol.41 , pp. 637-642
    • Fukasawa, M.1    Matsushita, K.2    Kamiyama, M.3    Mikami, Y.4    Araki, I.5    Yamagata, Z.6    Takeda, M.7
  • 6
    • 0026548912 scopus 로고
    • Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure
    • Vallance P, Leone A, Calver A, Collier J, Moncada S: Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet 339: 572-575, 1992
    • (1992) Lancet , vol.339 , pp. 572-575
    • Vallance, P.1    Leone, A.2    Calver, A.3    Collier, J.4    Moncada, S.5
  • 8
    • 38349019064 scopus 로고    scopus 로고
    • Asymmetrical dimethylarginine in renal disease: Limits of variation or variation limits? A systematic review
    • Jacobi J, Tsao PS: Asymmetrical dimethylarginine in renal disease: Limits of variation or variation limits? A systematic review. Am J Nephrol 28: 224-237, 2007
    • (2007) Am J Nephrol , vol.28 , pp. 224-237
    • Jacobi, J.1    Tsao, P.S.2
  • 10
    • 0026484859 scopus 로고
    • Percutaneous transvenous angioplasty in the treatment of vascular access stenosis
    • Beathard GA: Percutaneous transvenous angioplasty in the treatment of vascular access stenosis. Kidney Int 42: 1390-1397, 1992
    • (1992) Kidney Int , vol.42 , pp. 1390-1397
    • Beathard, G.A.1
  • 11
    • 0023463094 scopus 로고
    • The role of percutaneous angioplasty in the management of chronic hemodialysis fistulas
    • Glanz S, Gordon DH, Butt KM, Hong J, Lipkowitz GS: The role of percutaneous angioplasty in the management of chronic hemodialysis fistulas. Ann Surg 206: 777-781, 1987
    • (1987) Ann Surg , vol.206 , pp. 777-781
    • Glanz, S.1    Gordon, D.H.2    Butt, K.M.3    Hong, J.4    Lipkowitz, G.S.5
  • 13
    • 0032502337 scopus 로고    scopus 로고
    • Aortocoronary saphenous vein graft disease: Pathogenesis, predisposition, and prevention
    • Motwani JG, Topol EJ: Aortocoronary saphenous vein graft disease: Pathogenesis, predisposition, and prevention. Circulation 97: 916-931, 1998
    • (1998) Circulation , vol.97 , pp. 916-931
    • Motwani, J.G.1    Topol, E.J.2
  • 14
    • 33645468474 scopus 로고    scopus 로고
    • Hemodialysis vascular access dysfunction: A cellular and molecular viewpoint
    • Roy-Chaudhury P, Sukhatme VP, Cheung AK: Hemodialysis vascular access dysfunction: A cellular and molecular viewpoint. J Am Soc Nephrol 17: 1112-1127, 2006
    • (2006) J Am Soc Nephrol , vol.17 , pp. 1112-1127
    • Roy-Chaudhury, P.1    Sukhatme, V.P.2    Cheung, A.K.3
  • 15
    • 0036149851 scopus 로고    scopus 로고
    • Outcome and prognostic factors of restenosis after percutaneous treatment of native hemodialysis fistulas
    • Clark TW, Hirsch DA, Jindal KJ, Veugelers PJ, LeBlanc J: Outcome and prognostic factors of restenosis after percutaneous treatment of native hemodialysis fistulas. J Vasc Interv Radiol 13: 51-59, 2002
    • (2002) J Vasc Interv Radiol , vol.13 , pp. 51-59
    • Clark, T.W.1    Hirsch, D.A.2    Jindal, K.J.3    Veugelers, P.J.4    LeBlanc, J.5
  • 16
    • 3242750470 scopus 로고    scopus 로고
    • Dysfunctional autogenous hemodialysis fistulas: Outcomes after angioplasty: Are there clinical predictors of patency?
    • Rajan DK, Bunston S, Misra S, Pinto R, Lok CE: Dysfunctional autogenous hemodialysis fistulas: outcomes after angioplasty: Are there clinical predictors of patency? Radiology 232: 508-515, 2004
    • (2004) Radiology , vol.232 , pp. 508-515
    • Rajan, D.K.1    Bunston, S.2    Misra, S.3    Pinto, R.4    Lok, C.E.5
  • 17
    • 1942438521 scopus 로고    scopus 로고
    • Asymmetrical dimethylarginine: The Uber marker?
    • Cooke JP: Asymmetrical dimethylarginine: The Uber marker? Circulation 109: 1813-1818, 2004
    • (2004) Circulation , vol.109 , pp. 1813-1818
    • Cooke, J.P.1
  • 18
    • 0032893051 scopus 로고    scopus 로고
    • Accelerated intimal hyperplasia and increased endogenous inhibitors for NO synthesis in rabbits with alloxan-induced hyperglycaemia
    • Masuda H, Goto M, Tamaoki S, Azuma H: Accelerated intimal hyperplasia and increased endogenous inhibitors for NO synthesis in rabbits with alloxan-induced hyperglycaemia. Br J Pharmacol 126: 211-218, 1999
    • (1999) Br J Pharmacol , vol.126 , pp. 211-218
    • Masuda, H.1    Goto, M.2    Tamaoki, S.3    Azuma, H.4
  • 19
    • 0033667562 scopus 로고    scopus 로고
    • An endogenous inhibitor of nitric oxide synthase regulates endothelial adhesiveness for monocytes
    • Boger RH, Bode-Boger SM, Tsao PS, Lin PS, Chan JR, Cooke JP: An endogenous inhibitor of nitric oxide synthase regulates endothelial adhesiveness for monocytes. J Am Coll Cardiol 36: 2287-2295, 2000
    • (2000) J Am Coll Cardiol , vol.36 , pp. 2287-2295
    • Boger, R.H.1    Bode-Boger, S.M.2    Tsao, P.S.3    Lin, P.S.4    Chan, J.R.5    Cooke, J.P.6
  • 21
    • 0041733065 scopus 로고    scopus 로고
    • Asymmetric dimethylarginine causes hypertension and cardiac dysfunction in humans and is actively metabolized by dimethylarginine dimethylaminohydrolase
    • Achan V, Broadhead M, Malaki M, Whitley G, Leiper J, MacAllister R, Vallance P: Asymmetric dimethylarginine causes hypertension and cardiac dysfunction in humans and is actively metabolized by dimethylarginine dimethylaminohydrolase. Arterioscler Thromb Vasc Biol 23: 1455-1459, 2003
    • (2003) Arterioscler Thromb Vasc Biol , vol.23 , pp. 1455-1459
    • Achan, V.1    Broadhead, M.2    Malaki, M.3    Whitley, G.4    Leiper, J.5    MacAllister, R.6    Vallance, P.7
  • 22
    • 0023200487 scopus 로고
    • Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium
    • Radomski MW, Palmer RM, Moncada S: Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium. Lancet 2: 1057-1058, 1987
    • (1987) Lancet , vol.2 , pp. 1057-1058
    • Radomski, M.W.1    Palmer, R.M.2    Moncada, S.3
  • 23
    • 0030033842 scopus 로고    scopus 로고
    • Nitric oxide reversibly inhibits the migration of cultured vascular smooth muscle cells
    • Sarkar R, Meinberg EG, Stanley JC, Gordon D, Webb RC: Nitric oxide reversibly inhibits the migration of cultured vascular smooth muscle cells. Circ Res 78: 225-230, 1996
    • (1996) Circ Res , vol.78 , pp. 225-230
    • Sarkar, R.1    Meinberg, E.G.2    Stanley, J.C.3    Gordon, D.4    Webb, R.C.5
  • 26
    • 0034672521 scopus 로고    scopus 로고
    • Nitric oxide and postangioplasty restenosis: Pathological correlates and therapeutic potential
    • Janero DR, Ewing JF: Nitric oxide and postangioplasty restenosis: Pathological correlates and therapeutic potential. Free Radic Biol Med 29: 1199-1221, 2000
    • (2000) Free Radic Biol Med , vol.29 , pp. 1199-1221
    • Janero, D.R.1    Ewing, J.F.2
  • 28
    • 0032492738 scopus 로고    scopus 로고
    • Human endothelial nitric oxide synthase gene transfer inhibits vascular smooth muscle cell proliferation and neointima formation after balloon injury in rats
    • Janssens S, Flaherty D, Nong Z, Varenne O, van Pelt N, Haustermans C, Zoldhelyi P, Gerard R, Collen D: Human endothelial nitric oxide synthase gene transfer inhibits vascular smooth muscle cell proliferation and neointima formation after balloon injury in rats. Circulation 97: 1274-1281, 1998
    • (1998) Circulation , vol.97 , pp. 1274-1281
    • Janssens, S.1    Flaherty, D.2    Nong, Z.3    Varenne, O.4    van Pelt, N.5    Haustermans, C.6    Zoldhelyi, P.7    Gerard, R.8    Collen, D.9
  • 30
    • 0142209281 scopus 로고    scopus 로고
    • Plasma levels of asymmetrical dimethylarginine and adverse cardiovascular events after percutaneous coronary intervention
    • Lu TM, Ding YA, Lin SJ, Lee WS, Tai HC: Plasma levels of asymmetrical dimethylarginine and adverse cardiovascular events after percutaneous coronary intervention. Eur Heart J 24: 1912-1919, 2003
    • (2003) Eur Heart J , vol.24 , pp. 1912-1919
    • Lu, T.M.1    Ding, Y.A.2    Lin, S.J.3    Lee, W.S.4    Tai, H.C.5
  • 32
    • 4644326910 scopus 로고    scopus 로고
    • Inflammation and restenosis after percutaneous coronary interventions
    • Toutouzas K, Colombo A, Stefanadis C: Inflammation and restenosis after percutaneous coronary interventions. Eur Heart J 25: 1679-1687, 2004
    • (2004) Eur Heart J , vol.25 , pp. 1679-1687
    • Toutouzas, K.1    Colombo, A.2    Stefanadis, C.3
  • 33
    • 0037164104 scopus 로고    scopus 로고
    • Homocysteine and risk of ischemic heart disease and stroke: A meta-analysis
    • Homocysteine Studies Collaboration
    • Homocysteine Studies Collaboration: Homocysteine and risk of ischemic heart disease and stroke: A meta-analysis. JAMA 288: 2015-2022, 2002
    • (2002) JAMA , vol.288 , pp. 2015-2022
  • 37
    • 0344791653 scopus 로고    scopus 로고
    • Asymmetric dimethylarginine plasma concentrations differ in patients with end-stage renal disease: Relationship to treatment method and atherosclerotic disease
    • Kielstein JT, Boger RH, Bode-Boger SM, Schaffer J, Barbey M, Koch KM, Frolich JC: Asymmetric dimethylarginine plasma concentrations differ in patients with end-stage renal disease: Relationship to treatment method and atherosclerotic disease. J Am Soc Nephrol 10: 594-600, 1999
    • (1999) J Am Soc Nephrol , vol.10 , pp. 594-600
    • Kielstein, J.T.1    Boger, R.H.2    Bode-Boger, S.M.3    Schaffer, J.4    Barbey, M.5    Koch, K.M.6    Frolich, J.C.7
  • 38
    • 33750973371 scopus 로고    scopus 로고
    • Association of homocysteine and asymmetric dimethylarginine with atherosclerosis and cardiovascular events in maintenance hemodialysis patients
    • Kumagai H, Sakurai M, Takita T, Maruyama Y, Uno S, Ikegaya N, Kato A, Hishida A: Association of homocysteine and asymmetric dimethylarginine with atherosclerosis and cardiovascular events in maintenance hemodialysis patients. Am J Kidney Dis 48: 797-805, 2006
    • (2006) Am J Kidney Dis , vol.48 , pp. 797-805
    • Kumagai, H.1    Sakurai, M.2    Takita, T.3    Maruyama, Y.4    Uno, S.5    Ikegaya, N.6    Kato, A.7    Hishida, A.8
  • 39
    • 0036828019 scopus 로고    scopus 로고
    • Long-term angiotensin- converting enzyme inhibition reduces plasma asymmetric dimethylarginine and improves endothelial nitric oxide bioavailability and coronary microvascular function in patients with syndrome X
    • Chen JW, Hsu NW, Wu TC, Lin SJ, Chang MS: Long-term angiotensin- converting enzyme inhibition reduces plasma asymmetric dimethylarginine and improves endothelial nitric oxide bioavailability and coronary microvascular function in patients with syndrome X. Am J Cardiol 90: 974-982, 2002
    • (2002) Am J Cardiol , vol.90 , pp. 974-982
    • Chen, J.W.1    Hsu, N.W.2    Wu, T.C.3    Lin, S.J.4    Chang, M.S.5
  • 40
    • 0033594888 scopus 로고    scopus 로고
    • Novel mechanism for endothelial dysfunction: Dysregulation of dimethylarginine dimethylaminohydrolase
    • Ito A, Tsao PS, Adimoolam S, Kimoto M, Ogawa T, Cooke JP: Novel mechanism for endothelial dysfunction: Dysregulation of dimethylarginine dimethylaminohydrolase. Circulation 99: 3092-3095, 1999
    • (1999) Circulation , vol.99 , pp. 3092-3095
    • Ito, A.1    Tsao, P.S.2    Adimoolam, S.3    Kimoto, M.4    Ogawa, T.5    Cooke, J.P.6
  • 41
    • 0029360750 scopus 로고
    • Induction of NG-monomethyl-L-arginine uptake: A mechanism for differential inhibition of NO synthases?
    • Bogle RG, MacAllister RJ, Whitley GS, Vallance P: Induction of NG-monomethyl-L-arginine uptake: A mechanism for differential inhibition of NO synthases? Am J Physiol 269: C750-C756, 1995
    • (1995) Am J Physiol , vol.269
    • Bogle, R.G.1    MacAllister, R.J.2    Whitley, G.S.3    Vallance, P.4
  • 42
    • 34447525317 scopus 로고    scopus 로고
    • Angiotensin converting enzyme inhibitors maintain polytetrafluroethylene graft patency
    • Sajgure A, Choudhury A, Ahmed Z, Choudhury D: Angiotensin converting enzyme inhibitors maintain polytetrafluroethylene graft patency. Nephrol Dial Transplant 22: 1390-1398, 2007
    • (2007) Nephrol Dial Transplant , vol.22 , pp. 1390-1398
    • Sajgure, A.1    Choudhury, A.2    Ahmed, Z.3    Choudhury, D.4
  • 43
    • 0027462812 scopus 로고
    • Homocysteine and other thiols in plasma and urine: Automated determination and sample stability
    • Fiskerstrand T, Refsum H, Kvalheim G, Ueland PM: Homocysteine and other thiols in plasma and urine: Automated determination and sample stability. Clin Chem 39: 263-271, 1993
    • (1993) Clin Chem , vol.39 , pp. 263-271
    • Fiskerstrand, T.1    Refsum, H.2    Kvalheim, G.3    Ueland, P.M.4
  • 45
    • 0032785091 scopus 로고    scopus 로고
    • Reporting standards for percutaneous interventions in dialysis access. Technology Assessment Committee
    • Gray RJ, Sacks D, Martin LG, Trerotola SO: Reporting standards for percutaneous interventions in dialysis access. Technology Assessment Committee. J Vasc Interv Radiol 10: 1405-1415, 1999
    • (1999) J Vasc Interv Radiol , vol.10 , pp. 1405-1415
    • Gray, R.J.1    Sacks, D.2    Martin, L.G.3    Trerotola, S.O.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.